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Abstract.  Thymosin α-1 belongs to the small molecule family of thymo-
sines, which have been studied for a long time as molecules with very 
high potential use as drugs. In particular Thymosin α-1 is under inten-
sive studies for its use in different disorders and diseases such as respir-
atory distress syndrome, hepatitis C, hepatitis B, AIDS, cytomegalovirus 
infection etc. Thymosin α-1 is implicated in the control of gene expres-
sion of MHC I, MHC II, cytokines and other immune system regulators, 
but its molecular mechanism remains still unclear. On the other hand 
several studies were conducted with the aim to identify the structure of 
the peptide. In fact it was found that thymosin α-1 presents an α-helix 
conformation in fluorinated alcool/water mixtures but it is highly un-
structured in water solution. It is also presumed that very likely thymo-
sin α-1 presents an α-helix conformation when bound to the receptor. 
Here we present a MD simulation of a Poly Ethylen Oxide Diamine sta-
pled thymosin α-1 as a new strategy for the stabilization of its α-helix 
conformation in water solution. The PEO diamine stapled peptide pre-
sented a good overall stability also at high temperatures offering new 
insights into the design of more potent Thymosin α-1 derivative mole-
cules. 
 
Key words. Molecular dynamics, Thymosin α-1, REMD (Replica Exchange 
Molecular Dynamics),  Conformational analysis. 
 
Introduction. Thymosin α-1 (AcSDAAVDTSSEITTKDLKEKKEVVEEAEN) is a 
28 residue long peptide isolated for the first time from the calf thymus. It 
has been reported that this peptide produces a strong activation of T-cell 
differentiation and function [1]. In fact it is implicated in the control of 
gene expression of MHC I, MHC II, cytokines and other immune system 
regulators [2], but the real mechanism of action remains still unclear 
since no specific receptors have been identified. Thymosin α-1 is current-
ly used against infectious diseases such as respiratory distress syndrome,  
hepatitis C, hepatitis B, AIDS, cytomegalovirus infection and as anti tu-
moral where usually is administered subcutaneously [3]. It is produced in 
vivo by the cleavage action of a lysosomial asparagynil endopeptidase on 
the N-terminal region of prothymosin α, a 109 residue nuclear protein [4] 
and presents an acetate cap on its N-terminus. High field NMR spectros-
copy studies in DMPC/DMPA and in TFE/water mixtures demonstrated 
that the peptide adopts an α-helix conformation from residues 14 to 26 
and two double β-turns in the N-terminal region involving the first 12 
residues. Furthermore these NMR studies demonstrated that thymosin α
-1 is unstructured in water solution and proposed a model in which the 
interaction with cellular membranes is probably the first step toward the 
formation of a stable α-helix conformation and may play an important 
role in the mechanism of action [5,6]. In general the α-helix is a common 
element of protein secondary structure often involved in regulatory pro-
tein-protein interaction [7]. It is then straight forward the use of peptides 
for the construction of stable stand-alone secondary structures such as α-
helix with possible uses as agonists or antagonists bio-drugs presenting a 
better target recognition with respect to common small molecule ob-
tained from synthetic chemistry. Unfortunately the high conformational 
instability of peptides is a problem to overcome and often is the major 
cause for target binding failure. Obviously, stabilizing the α-helix confor-
mation of Thymosin α-1 in water solution is very important in order to 
understand the molecular mechanism of interaction with its cellular tar-
get. Moreover as demonstrated by a huge research literature, secondary 
structure stabilized peptides present 5 to 5000 fold increase in terms of 
target affinity [8,9] which will be of major interest in terms of Thymosin α
-1 dosing. There have been proposed several procedures for α-helix sta-
bilization which includes incorporation or modifications of single amino-
acids in order to introduce in the peptide the seeding of α-helix nuclea-
tion. Another very successful technique for α-helix stabilization is the all-
hydrocarbon α-helix staple. Briefly in such technique an olefinic chain is 
introduced between two modified aminoacids in the positions i, i+3; i, i+4 
or i, i+7, which induce and stabilize the α-helix conformation by macrocy-
clic bridge formation [10]. In this study we used Molecular Dynamics 
(MD) to access the stability of the stapled structures of Thymosin α-1. In 
contrast with the all-hydrocarbon α-helix staple, we propose the α-helix 
stapling of thymosin α-1 with Poly Ethylen Oxide (PEO) diamine for two 
important reasons: first PEO’s high tissue compatibility and second PEO’s 
high water solubility that may further limit Thymosin α-1 in the extracel-
lular compartment where this peptide is presumed to interact with its 
molecular targets. Moreover here we describe a strategy for the chemical 
synthesis of the PEO diamine stapled Thymosin α-1. 
 
Material and Methods. Initial structures of Thymosin α-1 were obtained 
from the published structure at www.pdb.org code 2L9I. Thymosin α-1 
and stapled Thymosin analogs were prepared according the protein prep-
aration workflow in Maestro and the Epik module [11]. Each peptide was 
then placed in a cubic cell, then water molecules and 0.150 M of NaCl 
was added using the System Builder module of the Desmond package 
[12,13]. The molecular dynamics simulations were performed using the 
OPLS 2005 force field and the TIP3P model for water molecules [14]. The 
long-range electrostatic interactions were calculated with the particle-
mesh Ewald method  (PME) [15] with a grid spacing of 0.8 Angstrom. On 
the other hand Van der Waals and short range electrostatic interactions 
were smoothly truncated at 9.0 Angstrom. The Desmond package offers 
a default protocol for system equilibration which was adopted in this 
work. Such protocol consists in a series of restrained minimizations which 
are very important for system minimization and which allow having an 
overall more realistic equilibrated system and a good starting point for 
the real and unrestrained molecular dynamics. Briefly the procedure 
consist of two rounds of steepest descent minimization and of four steps 
of molecular dynamics simulations were the first three are run as re-
strained for system relaxation and the last one is the unrestrained molec-
ular dynamics for system equilibration. The first simulation consist of a 12 
ps run at a temperature of 10 K maintaining constant the number of 
particles, volume, and temperature. The second run was a 12 ps simula-
tion performed at 10 K maintaining constant the number of particles, 
pressure, and temperature. The third run was a 24 ps simulation, during 
this run the temperature was raised to 300 K and the number of parti-
cles, pressure, and temperature was maintained constant. The last run 
was a 24 ps simulation performed at 300 K maintaining constant the 
number of particles, pressure, and temperature with all restraints re-
moved. After the system equilibration a long time molecular dynamic run 
of 5 ns was performed for each peptide (the Thymosin α-1 and the sta-
pled ones).  REMD (Replica Exchange Molecular Dynamics). During the 
replica exchange molecular dynamics (REMD) approach [16], a number of 
copies of the system in parallel evolves at different temperatures and 
periodically the configurations are exchanged between trajectories i and j 
with the probability 
 
Pij = exp(-D)      [Eq. 1] 
 
considering that D = (bi-bj) (Ej-Ei), where Ei is the potential energy at the 
temperature Ti and b=1⁄kBTi. The systems were prepared and relaxed as 
described earlier. In each case, during the REMD experiment 9 replicas of 
the system were evolved in parallel for 15 ns at constant NVT, with tem-
peratures varying between 300 and 500 K. Molecular Dynamics Analysis. 
The produced trajectories were analyzed with the VMD software [17] and 
modules there implemented able to read the Desmond output trajecto-
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ries in order to evaluate alpha helix dihedral angles and hydrogen bonds 
which were very important for the peptides conformation in each tem-
perature during for this study. The presence of the alpha helix confor-
mation  during each temperature was evaluated both from i, i+4  C=O....H 
bond within a distance of 3.8 Angstrom and a directional angle of 30° and 
by evaluating the Phi-Psi angles obtained during the REMD experiment. 
Free Energy Landscape. The free energy landscape or Potential of Mean 
Force [18] can be obtained by calculating the probability of finding a 
structure in a determined state expressed as a function of various reac-
tion coordinates and where n is any set of these reaction coordinates. 
 
P(n) =Z−1exp(−βw(n))      [Eq. 2] 
 
In these terms the free energy landscape is calculated from  
 
W(n2)−W(n1) = −RTlog(P(n2)/P(n1))      [Eq. 3] 
 
Here we will use the radius of gyration(Rg)and the backbone hydrogen 
bonds as reaction coordinates. The helix to coil transition. The thermo-
dynamic parameters for the helix to coil transition of the peptide were 
obtained by fitting the data obtained as previously described, to the Van't 
Hoff equation. 
lnK = −ΔH/RT + ΔS/R      [Eq. 4] 
 
The equilibrium constant Keq for the helix to coil transition obtained at 
each temperature describethe following equilibra. 
 
helix    ↔   coil 
 
Keq= [coil]/[helix] = (1-fh)/fh      [Eq. 5] 
 
Where fh represent the helix fraction and 1-fh represent the coil fraction 
calculated from each REMD trajectory as previously described. The evalu-
ation of the stability of each peptide was obtained from the helix temper-
ature of melting (Tm) calculated from: 
 
Tm= ΔH/ΔS      [Eq. 6] 
 
Results. The structures of the Thymosin α-1 and its stapled analog pep-
tides studied in this work are shown in the Figure 1. The PEO stapling was 
introduced strategically on the peptide between residue Glu 18 and Glu 
25 as PEO diamines, HNCH2CH2OCH2CH2OCH2CH2NH or HNCH2CH2O-
CH2CH2NH guided from synthesis strategy needs and were indicated as, 
Thymosi n-L (the one presenting the long PEO diamine chain) and Thymo-
si n-S (the one presenting the short PEO diamine chain). Conformational 
analysis. The conformations of each of the three peptides were analyzed 
in terms of alpha helix Hydrogen bonds and in terms of % of helicity that 
comes out from their Phi-Psi angles data during the REMD experiment. It 
was quite a surprise for us to observe that during the entire dynamic at 
300 K Thymosin α-1 maintain an overall high % (~ 30 %) of helicity. This 
was not justified by the experimental data which have demonstrated the 
absence of a secondary structure for this peptide in such conditions. This 
behavior is connected directly to the time of the observation during the 
REMD experiment which is very short (few ns).  Anyway this was not a 
real problem because increasing the temperature the percent of alpha 
helix in Thymosin α-1 decays very rapidly, which indicates a clear instabil-
ity of such structure in water.  On the other hand both of the stapled 
peptides behaved as expected. In fact we observed again a helix to coil 
transition but this time such arrangement takes place at higher tempera-
tures maintaining more than 20 % of the secondary structure also at 500 
K. In Figure 2, Figure 3 and Figure 4 are showed the distribution of Phi-Psi 
angles of Thymosin α-1, Thymosin-L and Thymosin-S during REMD trajec-
tories at the indicated temperatures. All angles distributions are found in 
four principal regions. The first region (green rectangle) presents a strong 
peak in the Phi range angle between -100°and -25° and Psi range angle 
between -50°and0°whichcorrespond to the α-helix region of the Rama-
chandran plot. The second region (pink rectangle) lie in the range of Psi 
angle between -30°, 30° and Phi range angle between -120°, -150° , the 
third region (red rectangle) lie in the range of Psi angle between 120°, 
170° and Phi range angle between-170, -50, the  fourth  region (purple 
rectangle) lies in the range of Psi angle between -150°, 50° and Phi range 
angle between 50°, 100°. Clearly we observe an increment of the density 
of angle population in the second, third and fourth region of the plots 
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Figure 1. Starting structures of Thymosin α-1 and its stapled analogs: In 
panel A) Thymosin α-1, in panel B) Thymosin-S and in C)Thymosin-L. The 
blue arrow indicates the stapling site on the peptide.  
Figure 2.  Ramachandran plots for Thymosin α-1 at A) 300 K;  B) 350 K and 
C) 400 K. In green Region 1; in pink Region 2; in red Region 3 and in pur-
ple Region 4. 
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with the increase of the temperature which is indicative of the helix to 
coil transition. Free Energy Landscape(FEL) profile of unfolding. The Free 
Energy Landscape plots are shown in Figure 5 and were generated using 
as reaction coordinates the backbone hydrogen bonds and radius of 
gyration obtained from the REMD trajectories for the tempera-tures 
indicated in the figure. In fact as we can observe from the panels a), d) 
and h) there are three to four local minima (blue color) presenting a Radi-
us of gyration in a) in the range of 11-13.5 Å in d) in the range of 10.5- 
12.5 Å and in h) in the range of 9.5 -12.5 and hydrogen bonds in the 
range of 20 to 10 bonds. The several local minima included in these re-
gions from the point of view of hydrogen backbone bonds may be includ-
ed in two principal classes: the first class which presents 1 or 2 folded 
states with 20-17 backbone hydrogen bonds and the second class which 
shows 1 or 2 partially unfolded states with 15-12 backbone hydro-gen 
bonds. This is clearly visible in Figure 6 showed here together with the 
representative structures as an example and correspond to Figure 5 panel 
a). In panels b), e) and g) we can observe the behavior of the peptides at 
350 K. At a first sight all the three peptides present an increase of Rg 
distance and are moving toward partially unfolded states judging from 
the decrease of the number of backbone hydrogen bonds. Moreover in 
panels c), f) and j) we can see what happens to the peptides structures at 
400 K. Differently from panel f) and j) where there is certainly a clear 
tendence to move toward partially unfolded states in the c) panel which 
correspond to Thymosin α-1 we can observe the presence of totally un-
folded states presenting less than 5 backbone hydrogen bonds and a Rg 
that goes from 12 to 15 Angstrom. This confirms not only what was found 
in precedent experimental studies about Thymosin α-1 and its instability, 
but gives also a clue about the increased stability of the stapled Thymosin 
α-1 analogs here named as Thymosin-L and Thymosin-S. Evaluation of 
the stability of the Thymosinα-1 and its stapled analogs from thermody-
namic parameters. In order to obtain the thermodynamic parameters 
and to evaluate the stability of structures studied in this work, the data 
were fitted to the Van’t Hoff equation [Eq.4] as described in Materials 
and methods. The equilibrium evaluated was focused on the transition 
from the folded state to the unfolded state. There was an overall good 
fitting to the equation as we can see from the R2 indices. Moreover in 
Table 1 are showed the calculated thermodynamic parameters obtained 
from such plots. As we can observe there is a decrease in enthalpy and 
entropy for both stapled peptides in comparison with Thymosin α-1 dur-
ing the helix to coil transition. Moreover we noticed that for both the 
stapled peptides, Thymosin-L and Thymosin-S there is a decrease in en-
tropic term higher than in the enthalpic one (numbers between paren-
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Figure 3. Ramachandran plots for Thymosin-L at A) 300 K;  B) 350 K and C) 
400 K. In green Region 1; in pink Region 2; in red Region 3 and in purple 
Region 4. 
Figure 4. Ramachandran plots for Thymosin-S at A) 300 K; B) 350 K and C) 
400 K. In green Region 1; in pink Region 2; in red Region 3 and in purple 
Region 4. 
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theses in Table 1). One may observe that the increased stability of the 
stapled peptides may derive from an entropic term. This result can be 
explained as due to the rigidity introduced by the stapling to the peptide 
which produces a more ordered structure, and in last analysis accounts 
for the increase of the peptide order. Infact as we can observe in Table 1 
the entropic term is decreased of about 1.5 fold in the stapled peptides 
compared to Thymosin α-1.  Furthermore the Tm calculated from Eq. 6 
was 293 K , 338 K and 359 K respectively for Thymosin α-1, Thymosin-L 
and Thymosin-S and the  ΔTm between stapled and not stapled forms of 
the Thymosine α-1 was 45 K and 66 K, indicating a major stability of the α
-helix structure for the stapled forms of the peptide compared with Thy-
mosin α-1. 
Discussion. Thymosin α-1 as previously mentioned is under different 
phases of clinical study in some countries and in use for some particular 
diseases in others [19]. Giving the great interest for this molecule we 
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Figure 5.  Free Energy Landscape of: Tymosin α-1 at a) 300 K;  b) 350 K 
and c) 400 K; Thymosin-L at d) 300 K;  e) 350 K and f)400 K;  Thymosin-S 
at h) 300 K;  g) 350 K and j) 400 K. 
Figure 6.  Free Energy Landscape of Tymosin α-1 at 300 K and conforma-
tional states of the peptide. 
Figure 7.  Van’t Hoff plots for helix to coil transition of A) Thymosin α-1
(R2= 0.95) B) Thymosin-L(R2= 0.99) and C) Thymosin-S(R2= 0.98). 
Molecule  ΔH(Kcal mol-1)  ΔS(Kcal K-1mol-1)  Tm (K)  
Thymosin  4.11  0.014  293  
Thymosin-L  3.18(22.6%)  0.009 (35.7%)  338  
Thymosin-S 3.59 (12.9%)  0.010 (28.6%)  359  
Table 1.  Thermodynamic parameters calculated from the Van’t Hoff plots 
for helix to coil transition. 
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here describe a possible method for its secondary structure stabilization 
in water solution which may be very important in terms of drug dosage 
or drug stability. In this work we demonstrated the stabilization of the 
secondary structure of Thymosin α-1 by PEO diamine stapling. The ther-
modynamic parameters, ΔH and ΔS, calculated here have the correct sign 
and are overall consistent with an ideal helix to coil transition considering 
the simplified system. Infact this modification induced an increase of the 
of Tm from 293 K (20° C) for Thymosin α-1 to 338 K (65°C) for Thymosin-L 
and 359 K (86° C) for Thymosin-S. This characteristic makes them good 
candidates for further evaluation in vitro or in cell studies. Choosing of 
the PEO diamine stapling was derived from two principal needs, first the 
synthesis strategy and second the biological compatibility in terms of 
weak immunogenicity and biocompatibility. Considerations for further 
developments. The Thymosin α-1 is a relatively long peptide and is quite 
difficult to obtain a good yield from classical chemical synthesis on resins 
with Nα-Fmoc aminoacids. Instead one may express it on E.coli strain or 
on Yeast cells by DNA recombinant technology and in a second moment 
try to staple it with PEO diamines. The coupling of the PEO diamines to 
the peptide can be obtained by dissolving them in Dichloromethane / 
Dimethylformamide (9:1) in order to link the Carboxyl groups of the lat-
eral chains of Glutamate or Aspartate residues as already described by 
other authors [20]. The use of organic solvents, which are good stabilizing 
agents for the alpha helix structure, is very important in order to block 
the structure of the peptide in its alpha helix conformation. After obtain-
ing the desired helicity one can proceed with the PEO diamine stapling 
reaction. Anyway during such synthesis we cannot exclude possible unde-
sired reactions that may produce intermolecular binding by undesired 
cross reactions. A possible solution may be the use of very low concentra-
tion of Thymosin α-1 and PEO diamine reagents during the reaction. 
 
Conclusion. We are aware that further studies are needed to fully ex-
plore the PEO diamine stapling as a stabilizing methodology on small 
peptides in order to use them as potential drugs. In fact it will be of great 
interest to explore the length of the stapling chain and its implication in 
the stability of the secondary alpha helix structure on Thymosin α-1 or in 
its biological effects. Moreover in vitro and cellular studies are needed to 
evaluate the biological effects of these new peptides. Anyway PEO dia-
mine stapled peptide presented a good overall stability also in high tem-
peratures offering new insights into the design of more potent Thymosin 
α-1 derivative molecules. The stapling strategy described here may find a 
broad use also on other peptides when needed to stabilize their second-
ary structure. 
 
Abbreviation. DMPC, Dimyristoylphosphatidylcholine; DMPA, Dimy-
ristoylphosphatidic acid; TFE Trifluoroethanol. MD, Molecular Dynam-
ics.NVT, constantnumber of atomsN, Volume V and TemperatureT. 
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